Company Filing History:
1 out of 2 
1 out of 3 Years Active: 2003
Title: László Ürögdi: Innovator in Molecular Chaperon Research
Introduction
László Ürögdi is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of molecular biology, particularly in the development of hydroxylamine derivatives that enhance molecular chaperon production. With a total of 2 patents, Ürögdi's work has the potential to impact various therapeutic applications.
Latest Patents
His latest patents include innovative methods for increasing the expression and activity of molecular chaperons in cells. One notable patent describes a method that involves treating cells exposed to physiological stress with effective amounts of specific hydroxylamine derivatives. This approach aims to enhance the stress response and improve cellular function. Another patent focuses on N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride, which is used in treating insulin resistance and related complications. This invention outlines methods for addressing diabetes-induced chronic complications, such as retinopathy and neuropathy.
Career Highlights
Throughout his career, László Ürögdi has worked with notable companies, including Biorex Research & Development Co. and Biorex Kutato Es Fejleszto Rt. His research has been instrumental in advancing the understanding of molecular chaperons and their applications in medicine.
Collaborations
Ürögdi has collaborated with esteemed colleagues, including Katalin Bíró and Mihály Barabás. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
László Ürögdi's contributions to molecular biology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic strategies for various health conditions.